Patanjali Divya Pharmacy’s five drugs placed under production ban

In the latest controversy, the Ayurveda and Unani Licensing Authority in Dehradun ordered Patanjali’s Divya Pharmacy to stop production of these five drugs which claimed to treat blood pressure, diabetes, goiter, glaucoma and hypercholesterolemia .

The Ayurveda and Unani Licensing Authority in Dehradun, Uttarakhand has asked Patanjali’s Divya Pharmacy to stop producing five drugs – Madhugiri, Eyegrit, Thyrogrit, BPgrit and Lipidom. Besides banning drug production, Patanjali was instructed to stop misleading advertisements immediately. The authority asked Patanjali to only offer future advertisements after approval from the authority.

Patanjali’s Divya Pharmacy said production could only restart after the authority approves the revised indications. The order comes after the company was accused of promoting the drugs to treat blood pressure, diabetes, goiter, glaucoma and high cholesterol.

The Uttarakhand Licensing Authority found “repeated breach of the provisions of the Medicines and Magical Remedies (Improper Advertisement) Act 1954 and the Medicines and Cosmetics Act 1940 and Rules of 1945” by Patanjali’s Divya Pharmacy.

A letter asking Patanjali’s Divya Pharmacy to stop manufacturing was sent on Wednesday, November 9.

CNBCTV18 awaits comments from Patanjali.

Comments are closed.